Royal Bank of Canada
AGN

Royal Bank of Canada’s Allergan plc AGN Stock Holding History

Royal Bank of Canada’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,319,993
Closed -$234M – 7167
2020
Q1 		$234M Sell
1,319,993
-1,321,503
-50% -$249M 0.11% 166
2019
Q4 		$505M Buy
2,641,496
+387,210
+17% +$69.9M 0.18% 113
2019
Q3 		$379M Buy
2,254,286
+1,293,382
+135% +$211M 0.15% 131
2019
Q2 		$161M Buy
960,904
+338,270
+54% +$46.8M 0.06% 252
2019
Q1 		$91.2M Buy
622,634
+49,668
+9% +$7.2M 0.04% 371
2018
Q4 		$76.6M Buy
572,966
+72,077
+14% +$11.8M 0.04% 395
2018
Q3 		$95.4M Sell
500,889
-86,061
-15% -$15.8M 0.04% 373
2018
Q2 		$97.9M Sell
586,950
-229,696
-28% -$36.9M 0.04% 335
2018
Q1 		$137M Buy
816,646
+153,364
+23% +$25.7M 0.06% 270
2017
Q4 		$108M Buy
663,282
+259,504
+64% +$46.6M 0.05% 315
2017
Q3 		$82.8M Sell
403,778
-140,902
-26% -$32.8M 0.04% 366
2017
Q2 		$132M Buy
544,680
+212,026
+64% +$49.8M 0.07% 241
2017
Q1 		$79.5M Buy
332,654
+9,686
+3% +$2.26M 0.04% 345
2016
Q4 		$67.8M Sell
322,968
-381,381
-54% -$79M 0.04% 400
2016
Q3 		$162M Buy
704,349
+205,071
+41% +$50.1M 0.09% 187
2016
Q2 		$115M Sell
499,278
-143,928
-22% -$33.2M 0.07% 226
2016
Q1 		$172M Sell
643,206
-46,437
-7% -$13.3M 0.11% 147
2015
Q4 		$216M Buy
689,643
+347,294
+101% +$103M 0.14% 117
2015
Q3 		$93.1M Sell
342,349
-153,093
-31% -$47M 0.07% 196
2015
Q2 		$150M Buy
495,442
+48,181
+11% +$14.4M 0.1% 147
2015
Q1 		$133M Buy
447,261
+128,768
+40% +$36.7M 0.09% 162
2014
Q4 		$82M Buy
318,493
+185,621
+140% +$46.4M 0.05% 270
2014
Q3 		$32.1M Buy
132,872
+50,253
+61% +$11.2M 0.02% 564
2014
Q2 		$18.4M Buy
82,619
+19,357
+31% +$4.01M 0.01% 843
2014
Q1 		$13M Sell
63,262
-186,840
-75% -$37M 0.01% 1002
2013
Q4 		$42M Buy
250,102
+93,545
+60% +$14.6M 0.03% 431
2013
Q3 		$22.5M Sell
156,557
-1,831
-1% -$244K 0.02% 663
2013
Q2 		$20M Buy
+158,388
New +$17.9M 0.02% 675

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Royal Bank of Canada's AGN Position: Q2 2020 in Review

Royal Bank of Canada sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,319,993 shares — an estimated $234M sold.

Royal Bank of Canada first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $505M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Royal Bank of Canada reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Royal Bank of Canada sold 1,319,993 Allergan plc shares in Q2 2020, an estimated $234M.
  • Royal Bank of Canada first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Royal Bank of Canada's Allergan plc position peaked at $505M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Royal Bank of Canada's 13F filing for Q2 2020, filed 14 Aug 2020.